Siren »

Niq Global Intelligence shares owned by Siren

Quarter-by-quarter ownership of Niq Global Intelligence shares owned by Siren from 13F filings

Historical chart of Siren investment in Niq Global Intelligence

Tip: Access up to 7 years of quarterly data

All positions including Niq Global Intelligence held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Niq Global Intelligence by Siren

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.5M 95k 15.70

More positions owned by Siren

Scholar Rock Hldg Corp (SRRK)
Kymera Therapeutics (KYMR)
BeOne Medicines Sponsored Ads (ONC)
Arrowhead Pharmaceuticals (ARWR)
Bicara Therapeutics (BCAX)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Crinetics Pharmaceuticals In (CRNX)
Edgewise Therapeutics (EWTX)
Disc Medicine (IRON)
Dyne Therapeutics (DYN)
Apellis Pharmaceuticals (APLS)
Avidity Biosciences Ord (RNA)
Stoke Therapeutics (STOK)
Lexicon Pharmaceuticals Com New (LXRX)
Rhythm Pharmaceuticals (RYTM)

View all positions for Siren

Top funds holding Niq Global Intelligence

Advent International Corporation
Kohlberg Kravis Roberts & Co
SurgoCap Partners
Ameriprise Financial
BlackRock
Vanguard Group
DnB NOR Asset Management AS
Alliancebernstein
Allspring Global Investments Holdings
Westfield Capital Management Company
Citadel Advisors
UBS Group
Alkeon Capital Management
Alyeska Investment Group
Select Equity

View all funds holding Niq Global Intelligence